[go: up one dir, main page]

DE60005300D1 - 2,3-o-isoproylidene derivativen von monosacchariden und verwendung als zell-adhäsion-inhibitoren - Google Patents

2,3-o-isoproylidene derivativen von monosacchariden und verwendung als zell-adhäsion-inhibitoren

Info

Publication number
DE60005300D1
DE60005300D1 DE60005300T DE60005300T DE60005300D1 DE 60005300 D1 DE60005300 D1 DE 60005300D1 DE 60005300 T DE60005300 T DE 60005300T DE 60005300 T DE60005300 T DE 60005300T DE 60005300 D1 DE60005300 D1 DE 60005300D1
Authority
DE
Germany
Prior art keywords
isoproylidene
monosaccharides
derivatives
cell adhesion
adhesion inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60005300T
Other languages
English (en)
Other versions
DE60005300T2 (de
Inventor
Sudershan K Arora
Nawal Kishore
Jang Bahadur Gupta
Vishwas D Joshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of DE60005300D1 publication Critical patent/DE60005300D1/de
Application granted granted Critical
Publication of DE60005300T2 publication Critical patent/DE60005300T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60005300T 1999-01-15 2000-01-10 2,3-o-isoproylidene derivativen von monosacchariden und verwendung als zell-adhäsion-inhibitoren Expired - Fee Related DE60005300T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (de) 1999-01-15 1999-01-15
INDE008699 1999-01-15
US276368 1999-03-25
US09/276,368 US6590085B1 (en) 1999-01-15 1999-03-25 Derivatives of monosaccharides as cell adhesion inhibitors
PCT/IB2000/000022 WO2000042054A1 (en) 1999-01-15 2000-01-10 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors

Publications (2)

Publication Number Publication Date
DE60005300D1 true DE60005300D1 (de) 2003-10-23
DE60005300T2 DE60005300T2 (de) 2004-07-15

Family

ID=11088155

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60005300T Expired - Fee Related DE60005300T2 (de) 1999-01-15 2000-01-10 2,3-o-isoproylidene derivativen von monosacchariden und verwendung als zell-adhäsion-inhibitoren

Country Status (31)

Country Link
US (5) US6590085B1 (de)
EP (1) EP1147119B1 (de)
JP (1) JP2002534530A (de)
CN (1) CN1167707C (de)
AR (1) AR022235A1 (de)
AT (1) ATE250074T1 (de)
AU (1) AU768511B2 (de)
BG (1) BG105745A (de)
BR (1) BR0007553A (de)
CA (1) CA2359986A1 (de)
CO (1) CO5180591A1 (de)
CR (1) CR6423A (de)
CZ (1) CZ20012540A3 (de)
DE (1) DE60005300T2 (de)
DK (1) DK1147119T3 (de)
ES (1) ES2206176T3 (de)
HK (1) HK1041270A1 (de)
HR (1) HRP20010529B1 (de)
HU (1) HUP0105116A3 (de)
ID (1) ID30351A (de)
IN (1) IN190975B (de)
MA (1) MA25342A1 (de)
MX (1) MXPA01007187A (de)
MY (1) MY121135A (de)
NZ (2) NZ512852A (de)
PA (1) PA8489901A1 (de)
PT (1) PT1147119E (de)
SK (1) SK284241B6 (de)
TR (1) TR200102043T2 (de)
WO (1) WO2000042054A1 (de)
YU (1) YU50701A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190975B (de) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
WO2004106299A2 (en) 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Substituted pyrrole derivatives and their use as hmg-co inhibitors
EP1789428A1 (de) * 2004-09-02 2007-05-30 Ranbaxy Laboratories Limited Monosaccharidderivate
WO2007063356A2 (en) * 2004-12-22 2007-06-07 Ranbaxy Laboratories Limited Derivatives of pentose monosaccharides as anti-inflammatory compounds
EP1915160A2 (de) * 2005-07-22 2008-04-30 Ranbaxy Laboratories Limited Derivate von monosacchariden zur behandlung von copd und der allergischen rhinitis
CA2627599A1 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
CL2007000667A1 (es) * 2006-03-14 2008-03-14 Ranbaxi Lab Ltd Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
EP1842855A3 (de) * 2006-03-29 2007-12-05 Ranbaxy Laboratories Limited Monosaccharidderivate als Entzündungshemmende und/oder Anti-Tumor Agentien
EP1864992A2 (de) * 2006-05-30 2007-12-12 Ranbaxy Laboratories, Ltd. Monosaccharidderivate
US20080300196A1 (en) * 2006-10-03 2008-12-04 Ashwani Kumar Verma Monosaccharide derivatives
US10034995B2 (en) * 2007-09-20 2018-07-31 Resmed Limited Retractable tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) * 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr) 1989-10-02 1995-06-02 Imaje Sa Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en) 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (de) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
MY121135A (en) 2005-12-30
BR0007553A (pt) 2001-12-18
ES2206176T3 (es) 2004-05-16
CN1343213A (zh) 2002-04-03
PA8489901A1 (es) 2000-09-29
US7037899B2 (en) 2006-05-02
AU768511B2 (en) 2003-12-18
EP1147119A1 (de) 2001-10-24
NZ512852A (en) 2004-02-27
CN1167707C (zh) 2004-09-22
HRP20010529A2 (en) 2002-08-31
IN190975B (de) 2003-09-06
SK284241B6 (en) 2004-11-03
US20040019191A1 (en) 2004-01-29
CO5180591A1 (es) 2002-07-30
WO2000042054A1 (en) 2000-07-20
MA25342A1 (fr) 2001-12-31
MXPA01007187A (es) 2002-04-24
US6590085B1 (en) 2003-07-08
DE60005300T2 (de) 2004-07-15
AU1886100A (en) 2000-08-01
ID30351A (id) 2001-11-22
ATE250074T1 (de) 2003-10-15
US20040018995A1 (en) 2004-01-29
HUP0105116A2 (hu) 2003-04-28
HUP0105116A3 (en) 2003-05-28
US7005516B2 (en) 2006-02-28
HK1041270A1 (en) 2002-07-05
AR022235A1 (es) 2002-09-04
US7005422B2 (en) 2006-02-28
CR6423A (de) 2004-03-09
NZ527483A (en) 2005-02-25
BG105745A (en) 2002-05-31
US20040029820A1 (en) 2004-02-12
DK1147119T3 (da) 2004-01-19
JP2002534530A (ja) 2002-10-15
SK10132001A3 (sk) 2002-01-07
TR200102043T2 (tr) 2001-11-21
CZ20012540A3 (cs) 2002-02-13
CA2359986A1 (en) 2000-07-20
HRP20010529B1 (en) 2005-02-28
US20040023900A1 (en) 2004-02-05
EP1147119B1 (de) 2003-09-17
YU50701A (sh) 2005-06-10
PT1147119E (pt) 2004-02-27

Similar Documents

Publication Publication Date Title
DE60036803D1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
ATE302193T1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
DE60030574D1 (de) Fünfgliedrige derivate von heterozyklen und ihre verwendung als monoaminoxidase-inhibitoren
DE69926154D1 (de) Pyridin-3-carbonsäurederivate und ihre Verwendung als Zwischenprodukte
DE69836346D1 (de) Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer
ATE277895T1 (de) 4-brom or 4-iod-phenylamino- benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren
DE59913617D1 (de) Indolderivate und deren Verwendung als Inhibitoren der Phosphodiesterase 4.
DE122009000014I1 (de) Substituierte oxazolidinone und ihre verwendung im gebiet der blutgerinnung
ATE323700T1 (de) Tetrahydropyridinderivate, deren herstellung und deren verwendung als inhibitoren der zellproliferation
DE60133897D1 (de) Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren
DE59703869D1 (de) Aminothiophencarbonsäureamide und ihre verwendung als phosphodiesterase inhibitoren
ATE277902T1 (de) Amidinoderivate und ihre verwendung als thrombininhibitoren
DE69818248D1 (de) Chinolin- und chinazolin-derivate als crf antagonisten
ATE421954T1 (de) Heteroaryl-hexansäureamid-derivate, ihre herstellung und ihre verwendung als selektive inhibitoren der bindung von mip-1-alpha an seinen ccr1 rezeptor
DE50012379D1 (de) Verwendung von nanoskaligen antischuppenwirkstoffen
ATE269349T1 (de) Derivativen von monosacchariden als zelladhäsionshemmer
DE69801878D1 (de) Verwendung von Oxamatderivaten als Depigmentierungsmittel
DE60005300D1 (de) 2,3-o-isoproylidene derivativen von monosacchariden und verwendung als zell-adhäsion-inhibitoren
DE60037183D1 (de) Neue amidinbenzylamin-derivate und ihre verwendung als thrombin-inhibitoren
DE69717647D1 (de) 3-mercaptoacetylamino-1,5-substituierte-2-oxo-azepan derivate und deren verwendung als inhibitoren von matrix-metalloproteinasen
ATE232207T1 (de) N-triazolyl-2-indolcarbonsäureamide und ihre verwendung als cck-a agonisten
ATE181071T1 (de) Piperidinessigsäurederivate und ihre verwendung als fibrinogenantagonistmittel
ATE253059T1 (de) Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer
ATE277023T1 (de) Indanderivate und ihre verwendung als zelladhäsionsinihibitoren
ATE229016T1 (de) Substituierte heterocyclische benzocycloalkene und ihre verwendung als analgetisch wirksame substanzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee